ASX
Mesoblast Limited
MSB:ASX•Healthcare
Sensitive ASX Announcement
CHF P3Trial Accrues Sufficient Primary EndPt Events(Correct)
Published: 17/12/19, 02:59pm (AEST)•2 pages